0.01
-49.15%
Close of 2 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About THC Farmaceuticals
Its shares trade under the ticker CBDG. It has been listed since 22 August 2012. In the fiscal year to 30 September 2022, it reported revenue of $10,000 and net income of $426,905. At that date it held total assets of $2.8m and shareholders' equity of $3.2m.
THC Farmaceuticals, Inc. engages in the research and development of pharmaceutical products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2012-08-22. The firm is also focused on ancillary products and services for the medical marijuana and legal recreational marijuana industry. The firm is engaged in performing research on plant terpenes, and is investigating the feasibility and marketability of terpene-based natural products. The firm was engaged in the placement and servicing of automated teller machines (ATMs) for public use, along the Wasatch Front in the State of Utah. As of June 30, 2015, it had approximately eight machines in operation.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Listed since
- 22 Aug 2012
Leadership
Pay as last reported
- Mr. Ed RosenthalPresident
- Mr. Eric MillerDirector, since 2014
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Established Reputation: THC Farmaceuticals Inc has built a strong reputation in the industry through its consistent delivery of high-quality products and services.
- Strong Distribution Network: The company has an extensive distribution network that allows it to reach a wide customer base efficiently.
- Innovative Research and Development: THC Farmaceuticals Inc invests in continuous research and development, resulting in the development of innovative and unique products.
Weaknesses
- Regulatory Environment: The cannabis industry is subject to strict regulations, which can pose challenges for THC Farmaceuticals Inc in terms of compliance and market access.
- Limited Product Portfolio: The company's product offerings are currently limited, which may hinder its ability to compete against companies with a more diverse range of products.
- Dependence on Third-Party Suppliers: THC Farmaceuticals Inc relies on external suppliers for certain raw materials, making it vulnerable to supply chain disruptions or quality issues.
Opportunities
- Growing Cannabis Market: The increasing acceptance and legalization of cannabis present significant opportunities for THC Farmaceuticals Inc to expand its market presence.
- Product Diversification: The company can explore new product lines and diversify its offerings to cater to a broader customer base and enhance revenue potential.
- International Expansion: With the global cannabis market evolving, THC Farmaceuticals Inc can explore expansion into new international markets and capitalize on emerging opportunities.
Threats
- Intense Competition: The cannabis industry is highly competitive, with numerous companies vying for market share. THC Farmaceuticals Inc faces the risk of increased competition from existing players as well as new entrants.
- Legal and Regulatory Changes: Changes in cannabis legislation and regulations can impact the company's operations, requiring adaptation to remain compliant and competitive.
- Economic Factors: Economic downturns or fluctuations can impact consumer spending on cannabis products, which could potentially affect THC Farmaceuticals Inc's sales and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.